Abstract
The relationship between the data obtained from provocative tests and the angiographically assessed coronary artery disease is usually expressed in terms of sensitivity and specificity. The need for a dichotomous (yes or no) classification of both the results of provocative tests and coronary angiography has at least three important limitations. Coronary artery disease is not an all or nothing condition: a binary classification requires arbitrary threshold criteria and creates artificial distinctions in coronary artery disease that, in actuality, shows a continuous spectrum of severity [1]. Sensitivity and specificity values tend to be affected by the disease distribution in the study population: a sample distribution with a high frequency of mild disease will be placed centrally near the threshold values where scatter is more likely to lower sensitivity and specificity [2]. Percentage diameter narrowing is not an adequate standard to quantify stenosis severity in clinical studies [3]: in unselected populations, this anatomic parameter has a poor correlation with the coronary flow reserve (see Chap. 2). Thus, coronary artery disease is a complex phenomenon which cannot be described adequately by means of a simple “normality versus disease” code; there are, in fact, significant differences as regards the degree and the extent of coronary artery disease, carrying important implications for both the therapeutic and the prognostic side. A stress test should therefore not only predict the presence/absence of coronary disease, but also stratify the disease severity. Accordingly, the diagnosis of myocardial ischemia by stress echocardiography should be delimited by time/space coordinates which represent: the circumferential (horizontal) extent of ischemia (x axis); the transmural (vertical) depth of ischemia (y axis); the ischemia-free stress time (i.e., the time from the start of the stress to the appearance of ischemia) (z axis) (Fig. 1).
If time and space, as sages say are things that cannot be the butterfly that lives a day has lived as long as we ...
... but time is time, and passes by though sages disagree
T.S. Eliot, Song
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Demer LL, Gould LK, Goldstein RA, Kirkeeide RL, Mullani NA, Smalling RW, Nishikawa A, Merhige ME (1989) Assessment of coronary artery disease severity by positron emission tomography. Comparison with quanitative arteriography in 193 patients. Circulation 79:825 —835
Hlatky MA, Mark DB, Harrell FE, Lee KL, Califf RM, Pryor DB (1987) Rethinking sensitivity and specificity. Am J Cardiol 59:1195 —1198
Marcus ML, Skorton DJ, Johnson MR, Collins SM, Harrison DG, Kerber RE (1988) Visual estimates of percent diameter coronary stenosis: a battered gold standard. J Am Coll Cardiol 11: 882 - 885
Bolognese L, Picano E, Orlandini A, D’Urbano M, Magaia O, Margaria F, Previtali F, Sclavo MG, Rosselli P, Chiarella F, Pirelli S, Raciti M, Landi P, Marini C, Lattanzi F (1990) High dose dipyridamole-echocardiography test early after acute myocardial infarction: large scale multicenter trial. Circulation 82 [4]: III - 74
Sheffield LT (1980) Exercise stress testing. In: Braunwald E (ed) Heart disease. A textbook of cardiovascular medicine. Saunders, Philadelphia
Armstrong WF (1988) Exercise echocardiography: ready, willing and able. J Am Coll Cardiol 11: 1359 - 1361
Simonetti I, Picano E, Lattanzi F, Marzilli M (1989) Dipyridamole echocardiography correlates with coronary lesion geometry in patients with limited coronary disease (abstr). Circulation 80: 338A
Picano E, Parodi O, Lattanzi F, Marcassa C, Sambuceti G, Bellina RC, Salvadori P, Camici P, L’Abbate A (1990) Noninvasive assessment of regional coronary flow reserve by dipyridamole echocardiography: correlation with ~ 3N-ammonia and positron emission tomography. J Am Coll Cardiol 15 [2]: 233A
Picano E, Severi S, Michelassi C, Lattanzi F, Masini M, Orsini E, Distante A, L’Abbate A (1989) Prognostic importance of dipyridamole-echocardiography test in coronary artery disease. Circulation 80: 450 - 457
Segar DS, Sawada SG, Brown SE, Ryan T, Armstrong WF, Feigenbaum H (1990) Dobutamine stress echocardiography: correlation of dose responsiveness and quantitative angiography. J Am Coll Cardiol 15: 234A
Amico A, Iliceto S, D’Ambrosio G, Sorino M, Coluccia P, Rizzon P (1987) Evaluation of timing of occurrence of wall motion abnormalities during incremental atrial pacing aids in the prediction of the severity of coronary artery disease. Eur Heart J 8: 190 - 194
Lattanzi F, Picano E, Bolognese L, Piccinino C, Sarasso G, Orlandini A, L’Abbate A (1991) Inhibition of dipyridamole induced ischemia by antianginal therapy in man: correlation with exercise-electrocardiography. Circulation 83:1256— 1262
Picano E, Lattanzi F, Distante A, L’Abbate A (1989) Role of myocardial oxygen consumption in dipyridamole induced ischemia. Am Heart J 118: 314 - 319
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Picano, E. (1992). Grading of Ischemic Response in Stress Echocardiography. In: Stress Echocardiography. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-13061-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-662-13061-2_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-13063-6
Online ISBN: 978-3-662-13061-2
eBook Packages: Springer Book Archive